The year 2013 started with a very successful meeting with the national and international advisors at Ahmedabad, which helped us to formulate our policy position on various matters.

The *Indian Journal of Dermatology* (IJD^®^) QUIZ became a hugely popular and successful module the moment it was initiated from the first issue of 2013. We are grateful to Ranbaxy for supporting this academic endeavor. We encourage all the IADVL members residing in India to take part in this exciting and edifying exercise. It would be pertinent to mention here about the other lucrative honors like IJD^®^ Ranbaxy awards for best original article and best case report. IJD-ISPD award is given for best article on pediatric dermatology published in IJD^®^ in any particular year. We are deeply obliged to the Indian Society for Paediatric Dermatology (ISPD) along with its chairperson Dr. Deepak Parikh and President Dr. Sandipan Dhar for initiating and nurturing this award.

Regularity and punctuality of publication is of utmost importance. We made it a habit and I am happy that we were able to bring out all the issues of 2013 dot on time. The online version is now updated days before the month starts. Credit goes to our cooperative authors, efficient editorial team, responsive reviewers, and proficient publisher\'s team at Wolters Kluwer Medknow.

Vital publication indicators like SCImago Journal ranking (SJR), cites per doc, total cites, total citable documents, and percentage of cited documents all have shown a very healthy and steady upward swing. The projected impact factor based on citation analysis of Wolters Kluwer Medknow has reached 0.636, which is almost double than that of last year.

As a result of all these, in 2013 we jumped five places in the SJR and reached the 27^th^ place among all the indexed Dermatology journals of the world.

Within a couple of years of creation, the dedicated Facebook group (<https://www.facebook.com/groups/181164148615686>) and the Facebook page (<https://www.facebook.com/pages/Indian-Journal-of-Dermatology/180893091923909?bookmark_t=page>) have created waves in the world of social media. In spite of being a closed, nonsearchable group, the membership of the IJD^®^ Facebook group has crossed 1900.! This underscores the popularity of the oldest surviving and first indexed Dermatology journal from Asia, especially among the younger generation.

From its inception almost six decades back, IJD^®^ has always been blessed with a very good number of quality articles from overseas authors. This year was no exception to this rule; 36% of our articles this year came from foreign locales. The eminence of any academic journal depends on the number of original articles submitted/published in it. In the last couple of years, we have witnessed a phenomenal 33% growth in the rate of submission of original articles to IJD^®^. Half of these original articles submitted are again from outside the country.

The H index has almost tripled during the past 2 years and has now reached a respectable figure of 12. This is an indication of significant qualitative improvement of the journal has achieved. Quantitatively also, we could publish a record number of 315 articles this year. Our policy regarding only e-publication of some of the articles has made this possible.

IJD^®^ Symposium has already established itself as a prestigious exclusivity of the journal for its class and consistency. In 2013 we could bring out three very high quality symposia on Psychodermatology, Integrative Dermatology, and Urticaria. We thank Dr. Shrutakirti Shenoi, Dr. S.R. Narahari, and Dr. Kiran Godse for graciously accepting the offer to be our guest editors and gladly and proficiently accomplishing the job in a time-bound manner.

We have introduced another exciting feature IJD^®^ spotlight where a few articles are presented as a bouquet on a focused topic. This year we could offer the readers three such interesting academic packages on psoriasis, clinical dermatology, and vitiligo research.

We have been able to finalize our policy positions relating to level of evidence and academic dishonesty. All readers, authors and reviewers are encouraged to go through the announcement in this regard carefully. After adopting CONSORT 2010 guidelines last year, as declared, we have decided to make preregistration of clinical trials a mandatory prerequisite while submitting any clinical trial in IJD^®^.

In 2005, we have observed a very successful IJD^®^ GoldCon to commemorate the golden jubilee celebration of the journal. In the annual GB meeting of the parent body IADVL, West Bengal it has been unanimously decided to celebrate the Diamond Jubilee year in 2015 in a befitting manner by organizing IJD^®^ DiamondCon.

Although the outcome is not always directly proportional to the effort exerted, I have nevertheless tried to offer the best that I can, with the help of the highly erudite, focused, and committed editorial board members, distinguished members of the editorial advisory board and extremely supportive Executive committee of IADVL, West Bengal State Branch and Asian Academy of Dermatology and Venereology.

I take this opportunity to thank our sponsors, namely, Ranbaxy, Galderma, Palsons Derma, Ajanta (Zillion and Avecea), Gracewell, and Ipca Bionova who stood by us like pillars. From the present issue IJD^®^ is getting thicker and will continue to reach almost all the dermatologists in the country. Thanks to the unbridled academic grant from Ranbaxy.

Before I sign off, on behalf of team IJD^®^, let me wish all of you a very happy, healthy, peaceful, prosperous, and productive 2014.

Long live the *Indian Journal of Dermatology* (IJD^®^)
